The effect of autologous blood on plantar fasciitis
Phase 3
Recruiting
- Conditions
- plantar fasciitis.Plantar fascial fibromatosisM72.2
- Registration Number
- IRCT20160508027797N7
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Age over 18 years
Heel pain for at least 4 weeks
Pain intensity greater than 5 based on visual analog scale index
Tenderness at the junction of plantar fascia with calcaneus
Having the ability to follow up for 6 months after starting treatment
Conscious written consent
Exclusion Criteria
Heel surgery
Evidence in favor of calcaneus fracture
Nerve damage
Achilles tendon injury
Rheumatoid Arthritis
Local or systemic infection
Peripheral vascular disorder
Gout
Coagulation disorder
Pregnancy or breastfeeding
Corticosteroid injection in the last 3 months
Use of non-steroidal anti-inflammatory drugs in the last 7 days
History of allergy to injectable solutions
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain control by autologous blood injection. Timepoint: First week, fourth week, third month, sixth month. Method of measurement: visual analogue scale index, role and maudsley scale.
- Secondary Outcome Measures
Name Time Method